A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment.


Journal

Current Alzheimer research
ISSN: 1875-5828
Titre abrégé: Curr Alzheimer Res
Pays: United Arab Emirates
ID NLM: 101208441

Informations de publication

Date de publication:
2020
Historique:
received: 20 03 2020
revised: 24 10 2020
accepted: 28 12 2020
pubmed: 16 2 2021
medline: 17 11 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Automated voxel-based analysis methods are used to detect cortical hypometabolism typical of Alzheimer's Disease (AD) on FDG-PET brain scans. We compared the accuracy of two clinically validated tools for their ability to identify those MCI subjects progressing to AD at followup, to evaluate the impact of the analysis method on FDG-PET diagnostic performance. SPMGrid and BRASS (Hermes Medical Solutions, Stockholm, Sweden) were tested on 131 MCI and elderly healthy controls from the EADC PET dataset. The concordance between the tools was tested by correlating the quantitative parameters (z- and t-values), calculated by the two software tools, and by measuring the topographical overlap of the abnormal regions (Dice score). Three independent expert readers blindly assigned a diagnosis based on the two map sets. We used conversion to AD dementia as the gold standard. The t-map and z-map calculated with SPMGrid and BRASS, respectively, showed a good correlation (R > .50) for the majority of individual cases (128/131) and for the majority of selected regions of interest (ROIs) (98/116). The overlap of the hypometabolic patterns from the two tools was, however, poor (Dice score .36). The diagnostic performance was comparable, with BRASS showing significantly higher sensitivity (.82 versus .59) and SPMGrid showing higher specificity (.87 versus .52). Despite similar diagnostic performance in predicting conversion to AD in MCI subjects, the two tools showed significant differences, and the maps provided by the tools showed limited overlap. These results underline the urgency for standardization across FDG-PET analysis methods for their use in clinical practice.

Identifiants

pubmed: 33583380
pii: CAR-EPUB-114183
doi: 10.2174/1567205018666210212162443
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1186-1194

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Valentina Garibotto (V)

Laboratory of Neuroimaging and Innovative Molecular Tracer, University of Geneva, Geneva, Switzerland.

Sara Trombella (S)

Laboratory of Neuroimaging and Innovative Molecular Tracer, University of Geneva, Geneva, Switzerland.

Luigi Antelmi (L)

University of Cote d'Azur, Inria Sophia Antipolis, Epione Research Project, Nice, France.

Paolo Bosco (P)

IRCCS Fondazione Stella Maris, Viale del Tirreno 331, Pisa, Italy.

Alberto Redolfi (A)

Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Claire Tabouret-Viaud (C)

Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, University Hospitals of Geneva, Geneva, Switzerland.

Olivier Rager (O)

Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, University Hospitals of Geneva, Geneva, Switzerland.

Gabriel Gold (G)

University of Geneva, Geneva, Switzerland.

Panteleimon Giannakopoulos (P)

University of Geneva, Geneva, Switzerland.

Silvia Morbelli (S)

Department of Nuclear Medicine, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.

Flavio Nobili (F)

Department of Nuclear Medicine, IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy.

Robert Perneczky (R)

Department of Psychiatry and Psychotherapy, Ludwig, Maximilians-Universitaet Muenchen, Munich, Germany.

Mira Didic (M)

Aix-Marseille Universite, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France.

Eric Guedj (E)

Aix-Marseille Universite, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France.

Alexander Drzezga (A)

Department of Nuclear Medicine, Technische Universitaet, Munich, Germany.

Rik Ossenkoppele (R)

Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, Netherlands.

Bart Van Berckel (BV)

Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, Netherlands.

Osman Ratib (O)

Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, University Hospitals of Geneva, Geneva, Switzerland.

Giovanni B Frisoni (GB)

Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH